Enzo Biochem Re-Schedules Teleconference to Discuss Second Quarter 2017 Results for This Afternoon, Monday, March 13, 2017 at...
March 13 2017 - 12:16PM
Business Wire
Enzo Biochem, Inc. (NYSE:ENZ), has rescheduled its planned
conference call to discuss fiscal 2017 second quarter results for
this afternoon, Monday, March 13, 2017, at 4:30 PM E.D.T.
A press release announcing second quarter results will be
distributed, Monday, March 13, 2017 after the market closes, as
originally announced.
To listen to the conference call dial 1-888-459-5609.
International callers can dial 1-973-321-1024. When prompted, use
PIN number 82073178. Dial in approximately ten minutes prior to the
scheduled teleconference time. A rebroadcast of the call will be
available starting approximately two hours after the conference
call ends, through midnight (E.D.T.) Monday, March 27, 2017. The
replay of the conference call can be accessed by dialing
1-800-585-8367 (International callers can dial 1-404-537-3406) and,
when prompted, use the same PIN number 82073178.
Enzo’s conference call can also be accessed live over the
Internet at: https://tinyurl.com/zn5vkrr
To listen to the live call, individuals should go to the web
site at least 15 minutes early to register, download and install
any necessary audio software. Any pop up blocker installed on your
PC should be disabled while accessing the webcast.
Enzo Biochem is engaged in the research, development and
manufacture of innovative health care products based on molecular
biology and genetic engineering techniques, and in providing
diagnostic services to the medical community.
Except for historical information, the matters discussed in this
news release may be considered "forward-looking" statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended and Section 21E of the Securities Exchange Act of 1934, as
amended. Such statements include declarations regarding the intent,
belief or current expectations of the Company and its management,
including those related to cash flow, gross margins, revenues, and
expenses are dependent on a number of factors outside of the
control of the company including, inter alia, the markets for the
Company’s products and services, costs of goods and services, other
expenses, government regulations, litigations, and general business
conditions. See Risk Factors in the Company’s Form 10-K for the
fiscal year ended July 31, 2016. Investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve a number of risks and uncertainties that
could materially affect actual results. The Company disclaims any
obligations to update any forward-looking statement as a result of
developments occurring after the date of this press release.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170313005982/en/
For Enzo Biochem, Inc.Steve Anreder,
212-532-3232steven.anreder@anreder.comorCEOcast, Inc.Michael Wachs,
212-732-4300mwachs@ceocast.com
Enzo Biochem (NYSE:ENZ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Enzo Biochem (NYSE:ENZ)
Historical Stock Chart
From Apr 2023 to Apr 2024